Product Liability Archive » January, 2008

Product Liability - January, 2008

166 articles

• Army Not Liable For Hurricane Katrina Errors: Judge
• EPA Launches Nanoscale Safety Data Program
• Manufacturer Agrees To Settle Cancer Cluster Case
• John Crane Ordered To Pay Asbestos Victim $15.3M
• Wyeth Victory In Prempro Lawsuit Survives Appeal
• Professor Raises Antitrust Issue In Vioxx Agreement
• $1B Deal On Zyprexa Still May Not End Lilly's Woes
• Toxic Exposure Claims Likely To Spike In Alabama
• Lawyers In Guidant MDL Spar Over $45M Fee Request
• Chinese Producer Of Abortion Pill Under Investigation
• Floridians Wrongly Shut Out Of Vioxx Deal: Lawyers
• Amicus Briefs Pile Up As Exxon Oral Argument Nears
• DuPont Superfund Suit Revived By High Court Orders
• Lawmakers Call On Mattel To Recall More Toys
• FDA Chastises Novartis Unit Over Safety Issues
• Hernia Patch Plaintiffs Play Hardball Over Names
• Dispute Derails Lead-Tainted Toy Train Settlement
• New Jersey Courts Claim Precedence In Cleanup Suit
• Criminal Prosecution Of Off-Label Drug Promotion
• Sonnenschein Lures Litigator From Locke Lord
• States To Investigate Vytorin Marketing Ploys
• FDA Must Step Up Medical Device Scrutiny: GAO
• Fosamax Judge Tosses Leftover Class Action Claims
• L. Tersigni Bids To Keep Heller Ehrman Report Private
• Nigerian Case Against Pfizer Runs Into Delay
• House Dems Raise Stink Over Formaldehyde Report
• Lawmakers Subpoena FDA, HHS Head In Ketec Probe
• Synthes Knowingly Sold Faulty Bone Implants: Suit
• Bausch & Lomb ReNu Tests Were Flawed: Study
• Product Safety Initiative Should Go Global: FDA
• Cordis Yanks Catheters Over Potentially Fatal Flaw
• VW Faces Class Action Over Fire Risk In Passat
• Allergan Punches Back At Botox Death Claims
• CORRECTED: Alaska Lawmakers Weigh In On Exxon Valdez Case
• Baxter Recalls Heparin Doses
• Following Recalls, EC Tightens Toy Safety Rules
• Lord Browne Deposition Limited In BP Explosion Suit
• Nanotechnology And The Power Of Innovation
• FDA To Eye Bluefin Tuna Over Mercury Fears
• Bayer Recalls Liquid Leukine For Adverse Effects
• Plaintiffs Scoff At Pfizer's Experts On Viagra Safety
• Total To Pay Damages In Spill While Planning Appeal
• Lawmakers Urge FDA To Rethink Drug Labeling
• As FDA Review Looms, Drug Cos. Defend Vytorin Study
• Dannon Accused Of Spooning Up Lies
• Can Lead Recall Class Actions Be Stopped At Once?
• Vendors, Law Firms Clash Over E-Discovery
• Asarco Seeks Court OK Of $27.9M Settlement
• Seroquel Plaintiffs Move To Quiz AstraZeneca's Drs.
• Judge May Oust 426 Plaintiffs From Baycol MDL
• Study Links Nexavar To Hypertension Risk
• Big Dig Consultants To Cough Up $458M
• Nissan Makes A Federal Case Of Possible Class Action
• Stryker Yanks Hip Implants After FDA Scolding
• J&J Battles Consolidation Of Ortho-Evra Lawsuits
• Merck, Schering Suspend TV Ads Touting Vytorin
• Judge Nixes Doctor Chats In Hernia Patch Case
• Manufacturer Expands Contaminated Syringe Recall
• Appeal Of Tire Safety Rule Falls Flat
• Health Co. Urges FDA To Ditch Calif.'s Proposition 65
• Lawmakers Blast Bush For Cutting 9/11 Health Plan
• Judge Lays Out Prempro Case Timetable
• RC2 Corp. Class Action Chugs To A Close
• New Details Emerge In Second Scruggs Scandal
• Judge Knocks Down Comair's Bid For Protective Order
• Court Tosses Part Of Design Defect Suit V. Honda
• NYC Fast Food Chains To Serve Up Calorie Counts
• EC To Propose New Toy Safety Directive
• Effects Of China-U.S. Safety Pact On U.S. Companies
• Supreme Court To Consider "Light" Cigarettes Case
• FDA's Cloned Foods Approval Sparks Labeling Debate
• FDA Aims To Bolster Oversight Of Drug Safety Data
• Pfizer Updates Chantix Label To Cite Possible Risks
• Delaware Debates Rules On Out-Of-State Plaintiffs
• High Court Agrees To Hear Wyeth Drug-Labeling Case
• FDA Issues Stiff Warning On Child Cold Medicine
• ConAgra Food Safety Exec Gets Pink Slip
• House Bill Aims To Improve Import Safety
• Regulators Blame Con Ed For Steam Pipe Explosion
• LG Washing Machines Gather Mold: Suit
• FDA's CBE Codification Could Help Defendants
• Antidepressant Makers Under Fire For Hiding Data
• NTSB Tiptoes Around Cause Of Bridge Collapse
• FDA Proposes Stricter Rules On Drug Label Changes
• As Special Master, She Sets Precedent
• N.Y. Wins $1.6M In Cleanup Costs From Polluters
• Judge Orders Libya To Pay $6B For Terrorist Attack
• Vytorin And Zetia Draw Suits And Scrutiny
• Stryker Wins Dismissal Of Squeaky Hip Implant Case
• Merck Bullish On Vioxx Deal As Deadline Passes
• FDA Shakes Head At Stryker's Plant Practices
• Device Debris Left In Patients Poses Peril: FDA
• Wyeth Fails In Bid To Dismiss Prempro Claim
• No Gain For Pain Of Wrongful Death: N.J. Governor
• Coast Guard Adopts New Oil Pollution Rule
• Federal Preemption Upheld In Heart Valve Case
• Defining "Coupon" Under the Class Action Fairness Act
• Amid Staunch Objections, FDA OKs Cloned Food
• Topps Liquidation Leaves Only Scraps For Creditors
• Justices Weigh Whether To Hear Preemption Case
• Pfizer And Plaintiffs Fight Over Experts In Viagra Case
• Scruggs' Lawyer Cops A Plea On Bribery Charge
• Class Action Over Bowflex Moved To Federal Court
• EU Vows To Keep Close Eye On "Frankenfoods"
• Plea To Leapfrog FDA's Drug Rules Denied Cert
• Thimerosal Testimony Barred In Wyeth Vaccine Case
• Decision Could Complicate Product Warning Labels
• Ex-Pfizer Director Granted Bail In Nigeria Drug Case
• Chemical Co. Hit With Suit Over 2004 Barge Spill
• L'Oreal Hit With Class Action Over Lead In Lipstick
• D-Day Arrives In Florida Tobacco Litigation
• R.I. Locals Win A Round In Toxic Tort V. Utility
• Org. Calls On Importers To Head Off Faulty Products
• Judge Lets $180M Settlement Flow In Flood Case
• Personal Injury Firm Sued For FLSA Violations
• Warning-Label Suit Against Swiss Banks Tossed
• Pfizer Wins Dismissal Of Lipitor Class Action
• Celebrex Plaintiffs Suffer Blow In Evidence Spat
• 6 Lawyers Migrate To Lewis Brisbois
• FDA Targets Pharmacies' Hormone Drug Marketing
• Class Action Says Ipex Sold Faulty Tubing
• Pharmacies May Tread On FDA Turf With HRTs
• N.J. Awaits Governor's OK On Wrongful Death Suit Bill
• Ohio Ruling Reflects Meaningful Tort Reform Efforts
• Attorney Duo Bolts From Scruggs' Side
• Bankrupt Co.'s Insurer To Pay $42M For Toxic Mess
• Sears Hit With Suit Over Customer Data Breaches
• TV Ads Minimize Drug Risks: Study
• Justices Deny Cert In Monsanto Mass Tort Case
• Growing "Cosmeceutical" Industry Faces Liability
• Jury Clears BP In $423M Cleanup Suit
• Ill Welder's Case Chosen As MDL Bellwether
• Lawmakers Leery Of Heart Doc's TV Plug For Lipitor
• Calif. Study Fails To Find Autism-Vaccine Link
• Washer Woes Stem From Misuse, Whirlpool Asserts
• Jan Marini Discontinues Second Eyelash Product
• Tronox To Settle Texarkana Toxic Tort
• Weyerhaeuser Loses Dispute Over Asbestos Claims
• Parties In Tainted Pet Food MDL Continue Talks
• Judge Tosses Consortium Claims In Plane Crash
• Attys Gripe At Vioxx Deal's All-Or-Nobody Provision
• Risks, Solutions For Toy Manufacturers In China
• More Evidence Of Anemia Drug Risk: FDA
• Appeals Court Refreshes Water Contamination Suit
• Judge Cuts $15M Award In Cruise Ship Illness Case
• FEMA's Trailer Headaches Continue To Grow
• Study Warns Pesticides May Cause Asthma In Women
• Eighth Circuit Reverses Course In Skyjack Case
• Diamond Pet Foods Settles Class Action For $3.1M
• Appeals Court Upholds $16M Judgment Against Q-Ray
• Whittier Farms Tied To Listeria Outbreak
• Merck Scores As Judge Spurns New Fosamax Class
• IBM Chemicals Caused Cancer: Suit
• Fujifilm Digital Camera Class Action Set To Continue
• Activists Sue FDA For Black Box Antibiotic Warnings
• Stand 'N Seal Plaintiffs Win Judge's Support For Trust
• Tribe Can't Bring Medical Monitoring Claims: Judge
• AstraZeneca Slams Seroquel Special Master's Report
• LG Nears Class Action Deal Over "Defective" HDTVs
• FDA May Pay Foes' Lawyers In Transplant Dispute
• Suit Says Sanofi Held Back Info On Obesity Drug
• Judge Seeks Zyprexa Litigation Cleanup
• Debate Heats Over Personal Injury Damages Caps
• Product Liability Litigation Drops From Peak
• Court Rejects $156M Verdict On Hamas Killing
• Medtronic Divvies Up $114M To Wind Down Suits